Literature DB >> 29771428

AMPK regulates energy metabolism through the SIRT1 signaling pathway to improve myocardial hypertrophy.

H-W Dong1, L-F Zhang, S-L Bao.   

Abstract

OBJECTIVE: We investigated the correlations of adenosine monophosphate-activated protein kinase (AMPK), Silence information regulator 1 (SIRT1) and energy metabolism with myocardial hypertrophy.
MATERIALS AND METHODS: Myocardial hypertrophy experimental model was established via transverse aortic constriction (TAC)-induced myocardial hypertrophy and phenylephrine (PE)-induced hypertrophic myocardial cell culture. After activation of AMPK, the messenger ribonucleic acid (mRNA) expressions in myocardial tissue- and myocardial cell hypertrophy-related genes, atrial natriuretic peptide (ANP) and β-myosin heavy chain (β-MHC), were detected. The production rate of 14C-labeled 14CO2 from palmitic acid was quantitatively determined to detect the fatty acid and glucose oxidation of hypertrophic myocardial tissues or cells, and the glucose uptake of myocardial cells was studied using [14C] glucose. Reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting were performed to detect the changes in SIRT1 mRNA and protein expressions in hypertrophic myocardial tissues. Moreover, SIRT1 small interfering ribonucleic acid (siRNA) was used to interfere in SIRT1 expression to further investigate the role of SIRT1 in the effect of AMPK activation on myocardial hypertrophy.
RESULTS: AMPK activation could significantly reduce the mRNA expressions of ANP and β-MHC in vitro and in vivo. AMPK could increase the ejection fraction (EF) and decrease the protein synthesis rate in myocardial cells in mice with myocardial hypertrophy. Besides, AMPK activation could increase the fatty acid oxidation, improve the glucose uptake and reduce the glucose oxidation. After AMPK activation, both SIRT1 mRNA and protein expressions in hypertrophic myocardial tissues and myocardial cells were increased. After SIRT1 siRNA was further used to interfere in SIRT1 expression in myocardial cells, it was found that mRNA expressions and protein synthesis rates of ANP and β-MHC were increased.
CONCLUSIONS: The activation of AMPK can inhibit the myocardial hypertrophy, which may be realized through regulating the myocardial energy metabolism via SIRT1 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29771428     DOI: 10.26355/eurrev_201805_14973

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  10 in total

Review 1.  The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review.

Authors:  Zahra Hajializadeh; Mohammad Khaksari
Journal:  Heart Fail Rev       Date:  2021-09-18       Impact factor: 4.214

2.  lncRNA NBR2 attenuates angiotensin II-induced myocardial hypertrophy through repressing ER stress via activating LKB1/AMPK/Sirt1 pathway.

Authors:  Cansheng Zhu; Min Wang; Xianguan Yu; Xing Shui; Leile Tang; Zefeng Chen; Zhaojun Xiong
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Vitamin D3 attenuates doxorubicin-induced senescence of human aortic endothelial cells by upregulation of IL-10 via the pAMPKα/Sirt1/Foxo3a signaling pathway.

Authors:  Lei Chen; Rachel Holder; Charles Porter; Zubair Shah
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

4.  Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?

Authors:  Gerwyn Morris; Basant K Puri; Andre Carvalho; Michael Maes; Michael Berk; Anu Ruusunen; Lisa Olive
Journal:  Int J Neuropsychopharmacol       Date:  2020-06-24       Impact factor: 5.176

5.  Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.

Authors:  Xin Wang; Youlu Lu; Zhouting Tuo; Huan Zhou; Ying Zhang; Zhangjun Cao; Longfei Peng; Dexin Yu; Liangkuan Bi
Journal:  Oncol Rep       Date:  2021-04-28       Impact factor: 3.906

6.  Liraglutide ameliorates myocardial damage in experimental diabetic rats by inhibiting pyroptosis via Sirt1/AMPK signaling.

Authors:  Zhe Zhang; Xing Wang; Linlin Yang; Linquan Yang; Huijuan Ma
Journal:  Iran J Basic Med Sci       Date:  2021-10       Impact factor: 2.699

7.  Downregulation of miR-128 Ameliorates Ang II-Induced Cardiac Remodeling via SIRT1/PIK3R1 Multiple Targets.

Authors:  Heqin Zhan; Feng Huang; Qian Niu; Mingli Jiao; Xumeng Han; Kaina Zhang; WenZhuo Ma; Shan Mi; Shiyu Guo; Zhenghang Zhao
Journal:  Oxid Med Cell Longev       Date:  2021-10-04       Impact factor: 6.543

Review 8.  Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go.

Authors:  Weida Qin; Jianghong Guo; Wenfeng Gou; Shaohua Wu; Na Guo; Yuping Zhao; Wenbin Hou
Journal:  Chin Herb Med       Date:  2022-03-23

Review 9.  Harnessing conserved signaling and metabolic pathways to enhance the maturation of functional engineered tissues.

Authors:  Neal I Callaghan; Lauren J Durland; Ronald G Ireland; J Paul Santerre; Craig A Simmons; Locke Davenport Huyer
Journal:  NPJ Regen Med       Date:  2022-09-03

Review 10.  Mitophagy: A Potential Target for Pressure Overload-Induced Cardiac Remodelling.

Authors:  Ruochen Shao; Junli Li; Tianyi Qu; Yanbiao Liao; Mao Chen
Journal:  Oxid Med Cell Longev       Date:  2022-09-27       Impact factor: 7.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.